FDA approved first cell Based gene therapy to treat adult and pediatric patients with Beta-thalassemia
On Aug. 17, 2022, the U.S. Food and Drug Administration announced it had approved Zynteglo (betibeglogene autotemcel), the…
-
-
Biotechnology | Vaccine | WHO
GSK awarded $170 million UNICEF contract for malaria vaccine
On Aug. 16, 2022, UNICEF announced that it had awarded a contract for the first ever supply of…
-
Medicines and Healthcare Products Regulatory Agency authorized Moderna’s Omicron-containing bivalent booster in the UK
On Aug. 15, 2022, Moderna announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK…
-
Roche launched new diagnostic test for the better understanding of immune response to SARS-CoV-2
On Aug. 15, 2022, Roche announced the launch of the Elecsys IGRA SARS-CoV-2 test in countries that accept…
-
Biotechnology | FDA | Infectious Disease | NIH | Therapeutics | Vaccine
U.S. Department of Health and Human Services made more vaccine doses available to support Mpox response
On Aug. 15, 2022, the U.S. Department of Health and Human Services announced that was making up to…
-
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea for use in adolescents aged 12 through 17
On Aug. 12, 2022, Novavax announced that partner, SK bioscience, had received a Post Approval Change Application approval…
-
WHO experts gave Mpox virus variants new names
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
-
Roche announced U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
On Aug. 11, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…
-
FDA authorized Emergency Use of JYNNEOS Mpox vaccine
On Aug. 9, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the…
-
NIH first to develop 3D structure of twinkle protein
On Aug. 5, 2022, researchers from the National Institutes of Health announced that they had developed a three-dimensional…
-
Agriculture | Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
CDC confirmed first human infection with flu virus from pigs during 2022
On Aug. 5, 2022, the Centers for Disease Control and Prevention (CDC) has reported the first human infection…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA approved first targeted therapy for HER2-low breast cancer
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
-
Novavax announced initiation of phase 2b/3 Hummingbird global clinical trial for COVID-19 vaccine in children aged six months through 11 years
On Aug. 4, 2022, Novavax announced the initiation of its Phase 2b/3 Hummingbird global clinical trial. The trial…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | U.S. Congress | Vaccine
U.S. Department of Health and Human Services declared Mpox a public health emergency
On Aug. 4, 2022, the U.S. Department of Health and Human Services declared the ongoing spread of monkeypox…
-
Nichelle Nichols Helped NASA Break Boundaries on Earth and in Space
On Jul. 31, 2022, the National Aeronautics and Space Administration (NASA) paid respects to actor Nichelle Nichols, who…
-
Scientists Sequence Genome of Watermelon seeds
On Jul. 30, 2022, scientists announced they had sequenced the genome of a 6,000-year-old Citrullus seeds that revealed…
-
Biotechnology | COVID-19 | NIH | Therapeutics | Vaccine
HHS announced 66 million doses of Moderna’s variant-specific COVID-19 vaccine booster for potential use in Fall and Winter 2022
On Jul. 29, 2022, the U.S. Department of Health and Human Services (HHS), in collaboration with the U.S….
-
AlphaFold revealed the structure of the protein universe
On Jul. 28, 2022, AlphaFold, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI), announced they we’re releasing predicted…
-
Cell by cell, scientists building a high-resolution map of brain changes in Alzheimer’s disease
On Jul. 28, 2022, the Allen Institute announced a newly released dataset of 1.2M cells from brain donors…
-
WHO recommended long-acting cabotegravir for HIV prevention
On Jul. 28, 2022, the World Health Organization (WHO) released new guidelines for the use of long-acting injectable…
-
BD, CerTest Biotec announced commercial launch of Mpox test
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
-
Pfizer and BioNTech announced clinical trial of next-generation vaccine candidate based on enhanced spike protein design
On Jul. 27, 2022, Pfizer and BioNTech announced that the companies had initiated a randomized, active-controlled, observer-blind, Phase…
-
Patient with HIV achieved remission following stem cell transplant
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
-
Biotechnology | CDC | Disease | Environmental | Therapeutics
Bacteria that causes rare disease Melioidosis discovered in U.S. environmental samples
On Jul. 27, 2022, the Centers for Disease Control and Prevention (CDC) announced that it had identified for…
-
Novavax Nuvaxovid COVID-19 vaccine granted provisional registration in Australia for use in adolescents aged 12 through 17
On Jul. 26, 2022, Novavax announced that the Australian Therapeutic Goods Agency had granted expanded approval for provisional…
-
Novavax announced expanded approval of Nuvaxovid COVID-19 vaccine for adolescents aged 12 through 17 in Japan
On Jul. 26, 2022, Novavax announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketing approval from…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Vacations Redux
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
-
EMA Committee for Medicinal Products for Human Use recommended use of the Moderna COVID-19 booster in adolescents (12-17 years)
On Jul. 23, 2022, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended…
-
Genome of 6,000-year-old wild watermelon sequenced
On Jul. 22, 2022, a team of scientists announced they had generated genome sequences from 6,000- and 3,300-year-old…
-
CHMP adopted positive opinion recommending Veklury (Remdesivir) receive full Marketing Authorization for teatment of patients with COVID-19
On Jul. 22, 2022, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
